Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Emerson Electric named as a Top Pick at Morgan Stanley » 09:30
03/29/23
03/29
09:30
03/29/23
09:30
EMR

Emerson Electric

$83.69 /

+0.95 (+1.15%)

, ETN

Eaton

$165.61 /

+1.6 (+0.98%)

, NATI

National Instruments

$51.99 /

-0.025 (-0.05%)

Morgan Stanley analyst…

Morgan Stanley analyst Joshua Pokrzywinski has named Emerson Electric (EMR) as a Top Pick, replacing the analyst's prior Top Pick Eaton (ETN). Emerson has emerged as "one of the few idiosyncractic stories in Multis" and the firm believes the catalyst path is positive, the analyst tells investors. Feedback from the firm's upgrade of shares last week was "mostly positive," with the main risk seen being Emerson potentially overpaying for National Instruments (NATI), which the firm believes has a "low probability." Morgan Stanley has an Overweight rating and $96 price target on Emerson shares.

ShowHide Related Items >><<
NATI National Instruments
$51.99 /

-0.025 (-0.05%)

ETN Eaton
$165.61 /

+1.6 (+0.98%)

EMR Emerson Electric
$83.69 /

+0.95 (+1.15%)

EMR Emerson Electric
$83.69 /

+0.95 (+1.15%)

03/21/23 Morgan Stanley
Emerson Electric upgraded to Overweight from Equal Weight at Morgan Stanley
03/06/23 UBS
Emerson Electric upgraded to Buy from Neutral at UBS
02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
ETN Eaton
$165.61 /

+1.6 (+0.98%)

03/14/23 UBS
Eaton price target raised to $197 from $173 at UBS
03/08/23 BofA
Eaton price target raised to $200 from $180 at BofA
02/09/23 Deutsche Bank
Eaton price target raised to $188 from $175 at Deutsche Bank
02/09/23 RBC Capital
Eaton price target raised to $161 from $149 at RBC Capital
NATI National Instruments
$51.99 /

-0.025 (-0.05%)

02/01/23 Baird
National Instruments downgraded to Neutral from Outperform at Baird
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
NATI National Instruments
$51.99 /

-0.025 (-0.05%)

ETN Eaton
$165.61 /

+1.6 (+0.98%)

EMR Emerson Electric
$83.69 /

+0.95 (+1.15%)

EMR Emerson Electric
$83.69 /

+0.95 (+1.15%)

NATI National Instruments
$51.99 /

-0.025 (-0.05%)

ETN Eaton
$165.61 /

+1.6 (+0.98%)

EMR Emerson Electric
$83.69 /

+0.95 (+1.15%)

NATI National Instruments
$51.99 /

-0.025 (-0.05%)

Over a week ago
On The Fly
Fly Intel: Pre-market Movers » 08:54
03/21/23
03/21
08:54
03/21/23
08:54
FRC

First Republic

$12.15 /

-10.84 (-47.15%)

, META

Meta Platforms

$197.76 /

+2.2 (+1.12%)

, EMR

Emerson Electric

$82.24 /

+1.41 (+1.74%)

, CSIQ

Canadian Solar

$35.81 /

+0.78 (+2.23%)

, ACDC

ProFrac Holding

$14.71 /

+0.3 (+2.08%)

, TME

Tencent Music

$7.87 /

+0.035 (+0.45%)

, HUYA

Huya

$3.92 /

+0.005 (+0.13%)

, XFOR

X4 Pharmaceuticals

/

+

, AG

First Majestic

$7.44 /

+0.12 (+1.64%)

, JPM

JPMorgan

$127.09 /

+1.32 (+1.05%)

, ONON

On Holding

$21.57 /

-0.02 (-0.09%)

Check out this morning's…

ShowHide Related Items >><<
XFOR X4 Pharmaceuticals
/

+

TME Tencent Music
$7.87 /

+0.035 (+0.45%)

ONON On Holding
$21.57 /

-0.02 (-0.09%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

HUYA Huya
$3.92 /

+0.005 (+0.13%)

FRC First Republic
$12.15 /

-10.84 (-47.15%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

CSIQ Canadian Solar
$35.81 /

+0.78 (+2.23%)

AG First Majestic
$7.44 /

+0.12 (+1.64%)

ACDC ProFrac Holding
$14.71 /

+0.3 (+2.08%)

FRC First Republic
$12.15 /

-10.84 (-47.15%)

03/21/23 Goldman Sachs
First Republic rating suspended at Goldman Sachs
03/20/23 Evercore ISI
Evercore ISI suspends rating on First Republic in light of uncertainty
03/20/23 Morgan Stanley
Morgan Stanley removes First Republic price target amid 'wide range of outcomes'
03/17/23 Atlantic Equities
First Republic downgraded to Neutral from Overweight at Atlantic Equities
META Meta Platforms
$197.76 /

+2.2 (+1.12%)

03/21/23 Morgan Stanley
Meta Platforms upgraded to Overweight from Equal Weight at Morgan Stanley
03/20/23 Loop Capital
Meta Platforms price target raised to $220 from $188 at Loop Capital
03/20/23 Edward Jones
Meta Platforms upgraded to Buy from Hold at Edward Jones
03/17/23 TD Cowen
Meta Platforms price target raised to $190 from $175 at TD Cowen
EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

03/21/23 Morgan Stanley
Emerson Electric upgraded to Overweight from Equal Weight at Morgan Stanley
03/06/23 UBS
Emerson Electric upgraded to Buy from Neutral at UBS
02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
CSIQ Canadian Solar
$35.81 /

+0.78 (+2.23%)

03/09/23 Citi
Canadian Solar transferred at Neutral from Buy at Citi
03/09/23 Citi
Canadian Solar downgraded to Neutral from Buy at Citi
02/09/23 Wells Fargo
Canadian Solar price target raised to $46 from $33 at Wells Fargo
01/30/23 Goldman Sachs
Canadian Solar price target raised to $36 from $33 at Goldman Sachs
ACDC ProFrac Holding
$14.71 /

+0.3 (+2.08%)

01/12/23 JPMorgan
ProFrac Holding price target raised to $32 from $30 at JPMorgan
01/10/23 Piper Sandler
ProFrac Holding price target raised to $35 from $31.50 at Piper Sandler
12/28/22 Stifel
ProFrac Holding addition of new assets a positive, says Stifel
11/14/22 Stifel
ProFrac Holding price target raised to $38 from $29 at Stifel
TME Tencent Music
$7.87 /

+0.035 (+0.45%)

01/19/23 86 Research
Tencent Music downgraded to Hold from Buy at 86 Research
12/01/22 Morgan Stanley
Tencent Music upgraded at Morgan Stanley with sustainable growth ahead
12/01/22 Morgan Stanley
Tencent Music upgraded to Overweight from Equal Weight at Morgan Stanley
11/22/22 JPMorgan
Tencent Music upgraded to Overweight from Neutral at JPMorgan (yesterday)
HUYA Huya
$3.92 /

+0.005 (+0.13%)

02/02/23 HSBC
Huya price target raised to $6.30 from $4.60 at HSBC
12/13/22 China Renaissance
China Renaissance upgrades Huya on end of regulation tightening
12/13/22 China Renaissance
Huya upgraded to Buy from Hold at China Renaissance
11/16/22 Citi
Huya downgraded to Sell at Citi on slower industry outlook
XFOR X4 Pharmaceuticals
/

+

12/22/22 Cantor Fitzgerald
X4 Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald
12/11/22 Piper Sandler
X4 Pharmaceuticals initiated with an Overweight at Piper Sandler
11/30/22 H.C. Wainwright
X4 Pharmaceuticals price target raised to $5 from $3.50 at H.C. Wainwright
08/05/22 H.C. Wainwright
X4 Pharmaceuticals price target lowered to $3.50 from $8.50 at H.C. Wainwright
AG First Majestic
$7.44 /

+0.12 (+1.64%)

02/27/23 TD Securities
First Majestic price target lowered to C$11 from C$12 at TD Securities
02/14/23 National Bank
First Majestic price target lowered to C$11 from C$14.50 at National Bank
01/20/23 BMO Capital
First Majestic price target lowered to C$9 from C$10.50 at BMO Capital
01/13/23 National Bank
First Majestic price target raised to C$14.50 from C$13 at National Bank
JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

03/13/23 Wells Fargo
Wells Fargo upgrades JPMorgan on 'Goliath is Winning' theme
03/13/23 Wells Fargo
JPMorgan upgraded to Overweight from Equal Weight at Wells Fargo
02/24/23 Morgan Stanley
JPMorgan price target raised to $173 from $167 at Morgan Stanley
02/08/23 Keefe Bruyette
Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform
ONON On Holding
$21.57 /

-0.02 (-0.09%)

03/16/23 Wedbush
Wedbush upgrades On Holding to Outperform, raises price target to $25
03/16/23 Wedbush
On Holding upgraded to Outperform from Neutral at Wedbush
03/13/23 UBS
On Holding price target raised to $27 from $25 at UBS
01/04/23 Piper Sandler
Wolverine World Wide downgraded to Neutral from Overweight at Piper Sandler
XFOR X4 Pharmaceuticals
/

+

TME Tencent Music
$7.87 /

+0.035 (+0.45%)

ONON On Holding
$21.57 /

-0.02 (-0.09%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

HUYA Huya
$3.92 /

+0.005 (+0.13%)

FRC First Republic
$12.15 /

-10.84 (-47.15%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

CSIQ Canadian Solar
$35.81 /

+0.78 (+2.23%)

ACDC ProFrac Holding
$14.71 /

+0.3 (+2.08%)

  • 08
    Feb
  • 07
    Dec
  • 02
    Aug
META Meta Platforms
$197.76 /

+2.2 (+1.12%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

HUYA Huya
$3.92 /

+0.005 (+0.13%)

FRC First Republic
$12.15 /

-10.84 (-47.15%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

CSIQ Canadian Solar
$35.81 /

+0.78 (+2.23%)

XFOR X4 Pharmaceuticals
/

+

TME Tencent Music
$7.87 /

+0.035 (+0.45%)

ONON On Holding
$21.57 /

-0.02 (-0.09%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

HUYA Huya
$3.92 /

+0.005 (+0.13%)

FRC First Republic
$12.15 /

-10.84 (-47.15%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

CSIQ Canadian Solar
$35.81 /

+0.78 (+2.23%)

TME Tencent Music
$7.87 /

+0.035 (+0.45%)

META Meta Platforms
$197.76 /

+2.2 (+1.12%)

JPM JPMorgan
$127.09 /

+1.32 (+1.05%)

FRC First Republic
$12.15 /

-10.84 (-47.15%)

AG First Majestic
$7.44 /

+0.12 (+1.64%)

ACDC ProFrac Holding
$14.71 /

+0.3 (+2.08%)

Upgrade
Emerson Electric upgraded to Overweight from Equal Weight at Morgan Stanley » 04:48
03/21/23
03/21
04:48
03/21/23
04:48
EMR

Emerson Electric

$82.24 /

+1.41 (+1.74%)

, NATI

National Instruments

$50.67 /

+0.13 (+0.26%)

Morgan Stanley upgraded…

Morgan Stanley upgraded Emerson Electric (EMR) to Overweight from Equal Weight with a price target of $96, up from $95. The stock's risk/reward is among the best in the sector with the National Instruments (NATI) resolution potentially being a "win-win as management lands an accretive deal or establishes its discipline," the analyst tells investors in a research note. The firm says Emerson's fundamentals are accelerating, particularly with liquified natural gas and hydrogen. It sees an attractive risk/reward at current share levels.

ShowHide Related Items >><<
NATI National Instruments
$50.67 /

+0.13 (+0.26%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

03/06/23 UBS
Emerson Electric upgraded to Buy from Neutral at UBS
02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
NATI National Instruments
$50.67 /

+0.13 (+0.26%)

02/01/23 Baird
National Instruments downgraded to Neutral from Outperform at Baird
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
01/17/23 Deutsche Bank
Emerson makes hostile bid for National Instruments, says Deutsche Bank
NATI National Instruments
$50.67 /

+0.13 (+0.26%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

NATI National Instruments
$50.67 /

+0.13 (+0.26%)

EMR Emerson Electric
$82.24 /

+1.41 (+1.74%)

NATI National Instruments
$50.67 /

+0.13 (+0.26%)

Hot Stocks
Emerson Electric selected to automate photovoltaic project in New Zealand » 09:05
03/14/23
03/14
09:05
03/14/23
09:05
EMR

Emerson Electric

$81.90 /

-0.21 (-0.26%)

Emerson will provide…

Emerson will provide advanced automation solutions to New Zealand's first large-scale solar photovoltaic power project within New Zealand's goal of achieving carbon neutrality by 2050. Emerson's renewable power generation expertise will help solar energy company Lodestone Energy complete its two 23 MW sites at Kaitaia and Edgecumbe.

ShowHide Related Items >><<
EMR Emerson Electric
$81.90 /

-0.21 (-0.26%)

EMR Emerson Electric
$81.90 /

-0.21 (-0.26%)

03/06/23 UBS
Emerson Electric upgraded to Buy from Neutral at UBS
02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
EMR Emerson Electric
$81.90 /

-0.21 (-0.26%)

EMR Emerson Electric
$81.90 /

-0.21 (-0.26%)

EMR Emerson Electric
$81.90 /

-0.21 (-0.26%)

Hot Stocks
Emerson selected to automate Golden Triangle Polymers facility » 09:17
03/13/23
03/13
09:17
03/13/23
09:17
EMR

Emerson Electric

$82.16 /

-1.29 (-1.55%)

, CVX

Chevron

$159.70 /

-0.75 (-0.47%)

, PSX

Phillips 66

$101.22 /

+0.14 (+0.14%)

Emerson (EMR) will…

Emerson (EMR) will provide automation technologies, software and analytics from its Plantweb digital ecosystem for the Golden Triangle Polymers Project, a world-scale integrated polymers facility on the Texas Gulf Coast. The total installed cost of the project is expected to be $8.5 billion and is a joint venture between Chevron Phillips Chemical Company, a company owned by Chevron (CVX) and Phillips 66 (PSX), and an indirect subsidiary of QatarEnergy. Operations are expected to begin in 2026. "The Golden Triangle Polymers Project and the recently announced Ras Laffan Petrochemical Complex in Qatar are among the world's largest ethane crackers, both leveraging Emerson's digital automation technologies, software and expertise to promote safer, smarter and more sustainable operations," said Ron Martin, Emerson's president, Americas. "We are proud to support Chevron Phillips Chemical's and QatarEnergy's track record of building world-class, optimized facilities."

ShowHide Related Items >><<
PSX Phillips 66
$101.22 /

+0.14 (+0.14%)

EMR Emerson Electric
$82.16 /

-1.29 (-1.55%)

CVX Chevron
$159.70 /

-0.75 (-0.47%)

EMR Emerson Electric
$82.16 /

-1.29 (-1.55%)

03/06/23 UBS
Emerson Electric upgraded to Buy from Neutral at UBS
02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
CVX Chevron
$159.70 /

-0.75 (-0.47%)

03/10/23 Mizuho
Chevron price target raised to $206 from $200 at Mizuho
03/02/23 Wells Fargo
Chevron price target lowered to $199 from $204 at Wells Fargo
02/24/23 TD Cowen
Chevron price target lowered to $170 from $185 at Cowen
01/31/23 Truist
Chevron price target raised to $179 from $169 at Truist
PSX Phillips 66
$101.22 /

+0.14 (+0.14%)

03/10/23 Mizuho
Phillips 66 price target lowered to $120 from $121 at Mizuho
03/08/23 UBS
UBS starts eight independent refiners with three Buys
03/08/23 UBS
Phillips 66 initiated with a Buy at UBS
01/12/23 Mizuho
DCP Midstream downgraded on Phillips 66 buyout at Mizuho
PSX Phillips 66
$101.22 /

+0.14 (+0.14%)

EMR Emerson Electric
$82.16 /

-1.29 (-1.55%)

CVX Chevron
$159.70 /

-0.75 (-0.47%)

PSX Phillips 66
$101.22 /

+0.14 (+0.14%)

EMR Emerson Electric
$82.16 /

-1.29 (-1.55%)

CVX Chevron
$159.70 /

-0.75 (-0.47%)

PSX Phillips 66
$101.22 /

+0.14 (+0.14%)

EMR Emerson Electric
$82.16 /

-1.29 (-1.55%)

CVX Chevron
$159.70 /

-0.75 (-0.47%)

PSX Phillips 66
$101.22 /

+0.14 (+0.14%)

CVX Chevron
$159.70 /

-0.75 (-0.47%)

On The Fly
Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations » 10:30
03/06/23
03/06
10:30
03/06/23
10:30
MNST

Monster Beverage

$103.05 /

+1.06 (+1.04%)

, HCP

HashiCorp

$33.51 /

+1.85 (+5.84%)

, EMR

Emerson Electric

$87.74 /

+2.2 (+2.57%)

, NATI

National Instruments

$51.24 /

+ (+0.00%)

, MTH

Meritage Homes

$111.36 /

+1.07 (+0.97%)

, VIR

Vir Biotechnology

$23.11 /

+0.275 (+1.20%)

, WEN

Wendy's

$21.76 /

-0.17 (-0.78%)

, RH

RH

$291.49 /

-5.8 (-1.95%)

, SI

Silvergate Capital

$6.15 /

+0.38 (+6.59%)

, DHI

D.R. Horton

$92.48 /

-0.27 (-0.29%)

, KBH

KB Home

$35.55 /

-0.215 (-0.60%)

, HR

Healthcare Realty Trust

$19.24 /

-0.21 (-1.08%)

, AAPL

Apple

$154.73 /

+3.65 (+2.42%)

, BMY

Bristol-Myers

$69.31 /

+0.01 (+0.01%)

, PFE

Pfizer

$41.13 /

-0.025 (-0.06%)

, LLY

Eli Lilly

$317.50 /

-0.98 (-0.31%)

, MRK

Merck

$108.10 /

+1.23 (+1.15%)

Want to get stock-moving…

ShowHide Related Items >><<
WEN Wendy's
$21.76 /

-0.17 (-0.78%)

VIR Vir Biotechnology
$23.11 /

+0.275 (+1.20%)

SI Silvergate Capital
$6.15 /

+0.38 (+6.59%)

RH RH
$291.49 /

-5.8 (-1.95%)

PFE Pfizer
$41.13 /

-0.025 (-0.06%)

NATI National Instruments
$51.24 /

+ (+0.00%)

MTH Meritage Homes
$111.36 /

+1.07 (+0.97%)

MRK Merck
$108.10 /

+1.23 (+1.15%)

MNST Monster Beverage
$103.05 /

+1.06 (+1.04%)

LLY Eli Lilly
$317.50 /

-0.98 (-0.31%)

KBH KB Home
$35.55 /

-0.215 (-0.60%)

HR Healthcare Realty Trust
$19.24 /

-0.21 (-1.08%)

HCP HashiCorp
$33.51 /

+1.85 (+5.84%)

EMR Emerson Electric
$87.74 /

+2.2 (+2.57%)

DHI D.R. Horton
$92.48 /

-0.27 (-0.29%)

BMY Bristol-Myers
$69.31 /

+0.01 (+0.01%)

AAPL Apple
$154.73 /

+3.65 (+2.42%)

MNST Monster Beverage
$103.05 /

+1.06 (+1.04%)

03/06/23 Redburn
Monster Beverage upgraded to Buy from Neutral at Redburn
03/01/23 BMO Capital
Monster Beverage price target raised to $105 from $97 at BMO Capital
03/01/23 Truist
Monster Beverage price target raised to $120 from $100 at Truist
03/01/23 Citi
Monster Beverage price target lowered to $118 from $121 at Citi
HCP HashiCorp
$33.51 /

+1.85 (+5.84%)

03/06/23 Needham
Needham upgrades HashiCorp to Buy on conservative 2023 estimates
03/06/23 Needham
HashiCorp upgraded to Buy from Hold at Needham
02/24/23 Scotiabank
HashiCorp initiated with a Sector Perform, $34 target at Scotiabank
02/23/23 Scotiabank
HashiCorp initiated with a Sector Perform at Scotiabank
EMR Emerson Electric
$87.74 /

+2.2 (+2.57%)

03/06/23 UBS
Emerson Electric upgraded to Buy from Neutral at UBS
02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
NATI National Instruments
$51.24 /

+ (+0.00%)

02/01/23 Baird
National Instruments downgraded to Neutral from Outperform at Baird
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
01/17/23 Deutsche Bank
Emerson makes hostile bid for National Instruments, says Deutsche Bank
MTH Meritage Homes
$111.36 /

+1.07 (+0.97%)

03/06/23 JPMorgan
Meritage Homes upgraded to Overweight from Neutral at JPMorgan
11/22/22 JPMorgan
Meritage Homes price target raised to $90 from $78 at JPMorgan
11/14/22 KeyBanc
Meritage Homes price target raised to $96 from $87 at KeyBanc
10/10/22 Wedbush
Meritage Homes price target lowered to $102 from $130 at Wedbush
VIR Vir Biotechnology
$23.11 /

+0.275 (+1.20%)

03/06/23 H.C. Wainwright
Vir Biotechnology price target lowered to $100 from $125 at H.C. Wainwright
03/06/23 JPMorgan
Vir Biotechnology upgraded to Overweight from Neutral at JPMorgan
02/21/23 Goldman Sachs
Vir Biotechnology upgraded to Buy from Neutral at Goldman Sachs
01/27/23 Morgan Stanley
Vir Biotechnology upgraded to Equal Weight from Underweight at Morgan Stanley
WEN Wendy's
$21.76 /

-0.17 (-0.78%)

03/06/23 Northcoast
Wendy's downgraded to Neutral at Northcoast on profit headwinds, share risk
03/06/23 Northcoast
Wendy's downgraded to Neutral from Buy at Northcoast
01/17/23 Truist
Wendy's price target raised to $28 from $27 at Truist
01/16/23 Deutsche Bank
Wendy's downgraded to Hold from Buy at Deutsche Bank
RH RH
$291.49 /

-5.8 (-1.95%)

03/06/23 Jefferies
RH cut to Hold at Jefferies with luxury housing market 'struggling to stabilize'
03/06/23 Jefferies
RH downgraded to Hold from Buy at Jefferies
02/07/23 Barclays
Barclays sees a 'reset' in U.S. retail but 'not a recession yet'
02/07/23 Barclays
RH assumed with an Equal Weight at Barclays
SI Silvergate Capital
$6.15 /

+0.38 (+6.59%)

03/06/23 Compass Point
Silvergate Capital downgraded to Sell from Neutral at Compass Point
03/06/23 Wedbush
Wedbush downgrades Silvergate Capital to Underperform, lowers price target to $4
03/06/23 Wedbush
Silvergate Capital downgraded to Underperform from Neutral at Wedbush
03/02/23 Goldman Sachs
Goldman suspends Silvergate rating on 'insufficient information'
DHI D.R. Horton
$92.48 /

-0.27 (-0.29%)

03/06/23 JPMorgan
D.R. Horton downgraded to Neutral from Overweight at JPMorgan
01/25/23 BTIG
D.R. Horton price target raised to $108 from $101 at BTIG
01/25/23 JMP Securities
D.R. Horton price target raised to $115 from $95 at JMP Securities
01/25/23 Wedbush
Wedbush downgrades D.R. Horton to Neutral, lowers price target to $96
KBH KB Home
$35.55 /

-0.215 (-0.60%)

03/06/23 JPMorgan
KB Home downgraded to Underweight from Overweight at JPMorgan
01/13/23 BTIG
KB Home earnings miss driven by fewer deliveries, says BTIG
01/13/23 RBC Capital
KB Home downgraded to Sector Perform from Outperform at RBC Capital
01/12/23 UBS
KB Home price target lowered to $45 from $48 at UBS
HR Healthcare Realty Trust
$19.24 /

-0.21 (-1.08%)

03/06/23 Credit Suisse
Healthcare Realty Trust downgraded to Neutral from Outperform at Credit Suisse
01/30/23 Citi
Citi opens 'Catalyst Watches' into REITs, lodging earnings reports
12/14/22 Citi
Healthcare Realty Trust downgraded to Neutral from Buy at Citi
11/10/22 Barclays
Healthcare Realty Trust price target lowered to $28 from $33 at Barclays
AAPL Apple
$154.73 /

+3.65 (+2.42%)

03/06/23 BofA
Apple App Store revenue growth 'still muted' in fiscal Q2-to-date, says BofA
03/05/23 Goldman Sachs
Apple initiated with a Buy at Goldman Sachs
03/03/23 Barclays
Google facing query share loss for first time ever, says Barclays
03/03/23 Morgan Stanley
Morgan Stanley sees catalysts for top pick Apple, ups price target
BMY Bristol-Myers
$69.31 /

+0.01 (+0.01%)

03/06/23 Jefferies
Jefferies starts 'optically cheap' Bristol-Myers at Hold on structural concerns
03/06/23 Jefferies
Bristol-Myers initiated with a Hold at Jefferies
01/19/23 Piper Sandler
Amgen price target cut at Piper on lower Otezla estimates
01/17/23 Cantor Fitzgerald
Bristol-Myers initiated with an Overweight at Cantor Fitzgerald
PFE Pfizer
$41.13 /

-0.025 (-0.06%)

03/06/23 Jefferies
Jefferies starts Pfizer with a Hold on lack of visibility
03/06/23 Jefferies
Pfizer initiated with a Hold at Jefferies
03/03/23 SVB Securities
SVB says Pfizer could create value for holders with Seagen bid up to $253
02/28/23 Oppenheimer
Seagen price target raised to $210 from $180 at Oppenheimer
LLY Eli Lilly
$317.50 /

-0.98 (-0.31%)

03/06/23 Jefferies
Jefferies starts 'priced to perfection' Eli Lilly with a Hold
03/06/23 Jefferies
Eli Lilly initiated with a Hold at Jefferies
03/02/23 Morgan Stanley
Novo Nordisk named 'Catalyst Driven Idea' at Morgan Stanley
02/24/23 Jefferies
Nektar downgraded to Underperform from Hold at Jefferies
MRK Merck
$108.10 /

+1.23 (+1.15%)

03/06/23 Jefferies
Merck initiated with a Buy at Jefferies
02/23/23 JPMorgan
Merck shares positioned for further upside, says JPMorgan
02/22/23 Wolfe Research
Wolfe upgrades Merck with pipeline 'big enough to matter'
WEN Wendy's
$21.76 /

-0.17 (-0.78%)

VIR Vir Biotechnology
$23.11 /

+0.275 (+1.20%)

SI Silvergate Capital
$6.15 /

+0.38 (+6.59%)

RH RH
$291.49 /

-5.8 (-1.95%)

PFE Pfizer
$41.13 /

-0.025 (-0.06%)

NATI National Instruments
$51.24 /

+ (+0.00%)

MTH Meritage Homes
$111.36 /

+1.07 (+0.97%)

MRK Merck
$108.10 /

+1.23 (+1.15%)

MNST Monster Beverage
$103.05 /

+1.06 (+1.04%)

LLY Eli Lilly
$317.50 /

-0.98 (-0.31%)

KBH KB Home
$35.55 /

-0.215 (-0.60%)

HR Healthcare Realty Trust
$19.24 /

-0.21 (-1.08%)

HCP HashiCorp
$33.51 /

+1.85 (+5.84%)

EMR Emerson Electric
$87.74 /

+2.2 (+2.57%)

DHI D.R. Horton
$92.48 /

-0.27 (-0.29%)

BMY Bristol-Myers
$69.31 /

+0.01 (+0.01%)

AAPL Apple
$154.73 /

+3.65 (+2.42%)

VIR Vir Biotechnology
$23.11 /

+0.275 (+1.20%)

SI Silvergate Capital
$6.15 /

+0.38 (+6.59%)

PFE Pfizer
$41.13 /

-0.025 (-0.06%)

MRK Merck
$108.10 /

+1.23 (+1.15%)

MNST Monster Beverage
$103.05 /

+1.06 (+1.04%)

LLY Eli Lilly
$317.50 /

-0.98 (-0.31%)

HCP HashiCorp
$33.51 /

+1.85 (+5.84%)

EMR Emerson Electric
$87.74 /

+2.2 (+2.57%)

DHI D.R. Horton
$92.48 /

-0.27 (-0.29%)

BMY Bristol-Myers
$69.31 /

+0.01 (+0.01%)

AAPL Apple
$154.73 /

+3.65 (+2.42%)

WEN Wendy's
$21.76 /

-0.17 (-0.78%)

VIR Vir Biotechnology
$23.11 /

+0.275 (+1.20%)

SI Silvergate Capital
$6.15 /

+0.38 (+6.59%)

RH RH
$291.49 /

-5.8 (-1.95%)

PFE Pfizer
$41.13 /

-0.025 (-0.06%)

NATI National Instruments
$51.24 /

+ (+0.00%)

MTH Meritage Homes
$111.36 /

+1.07 (+0.97%)

MRK Merck
$108.10 /

+1.23 (+1.15%)

MNST Monster Beverage
$103.05 /

+1.06 (+1.04%)

LLY Eli Lilly
$317.50 /

-0.98 (-0.31%)

KBH KB Home
$35.55 /

-0.215 (-0.60%)

HCP HashiCorp
$33.51 /

+1.85 (+5.84%)

EMR Emerson Electric
$87.74 /

+2.2 (+2.57%)

DHI D.R. Horton
$92.48 /

-0.27 (-0.29%)

BMY Bristol-Myers
$69.31 /

+0.01 (+0.01%)

AAPL Apple
$154.73 /

+3.65 (+2.42%)

WEN Wendy's
$21.76 /

-0.17 (-0.78%)

SI Silvergate Capital
$6.15 /

+0.38 (+6.59%)

RH RH
$291.49 /

-5.8 (-1.95%)

PFE Pfizer
$41.13 /

-0.025 (-0.06%)

NATI National Instruments
$51.24 /

+ (+0.00%)

MRK Merck
$108.10 /

+1.23 (+1.15%)

MNST Monster Beverage
$103.05 /

+1.06 (+1.04%)

LLY Eli Lilly
$317.50 /

-0.98 (-0.31%)

KBH KB Home
$35.55 /

-0.215 (-0.60%)

HCP HashiCorp
$33.51 /

+1.85 (+5.84%)

DHI D.R. Horton
$92.48 /

-0.27 (-0.29%)

BMY Bristol-Myers
$69.31 /

+0.01 (+0.01%)

AAPL Apple
$154.73 /

+3.65 (+2.42%)

Upgrade
Emerson Electric upgraded to Buy from Neutral at UBS » 05:57
03/06/23
03/06
05:57
03/06/23
05:57
EMR

Emerson Electric

$85.55 /

+1.77 (+2.11%)

, NATI

National Instruments

$51.24 /

+0.63 (+1.24%)

UBS analyst Chris Snyder…

UBS analyst Chris Snyder upgraded Emerson Electric (EMR) to Buy from Neutral with a price target of $97, down from $100, following the January 4 downgrade. The firm finds the recent derating overdone, and while UBS has been critical of a potential National Instruments (NATI) deal, thinks the market-implied $10B value erosion "seems excessive," the analyst tells investors in a research note. Assuming an $8B acquisition of National Instruments, the firm's math suggests Emerson still has $4B incremental dry powder.

ShowHide Related Items >><<
EMR Emerson Electric
$85.55 /

+1.77 (+2.11%)

EMR Emerson Electric
$85.55 /

+1.77 (+2.11%)

02/21/23 TD Cowen
Emerson Electric price target lowered to $105 from $115 at Cowen
02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
02/09/23 Deutsche Bank
Deutsche Bank keeps Hold on Emerson Electric, lowers price target to $93
NATI National Instruments
$51.24 /

+0.63 (+1.24%)

02/01/23 Baird
National Instruments downgraded to Neutral from Outperform at Baird
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
01/17/23 Deutsche Bank
Emerson makes hostile bid for National Instruments, says Deutsche Bank
01/17/23 Baird
National Instruments price target raised to $50 from $46 at Baird
NATI National Instruments
$51.24 /

+0.63 (+1.24%)

EMR Emerson Electric
$85.55 /

+1.77 (+2.11%)

EMR Emerson Electric
$85.55 /

+1.77 (+2.11%)

NATI National Instruments
$51.24 /

+0.63 (+1.24%)

EMR Emerson Electric
$85.55 /

+1.77 (+2.11%)

NATI National Instruments
$51.24 /

+0.63 (+1.24%)

Over a month ago
Recommendations
Emerson Electric price target lowered to $105 from $115 at Cowen » 07:38
02/21/23
02/21
07:38
02/21/23
07:38
EMR

Emerson Electric

$85.43 /

-0.285 (-0.33%)

Cowen analyst Gautam…

Cowen analyst Gautam Khanna lowered the firm's price target on Emerson Electric to $105 from $115 and keeps an Outperform rating on the shares. The analyst said its Q1's EPS miss overshadowed strong underlying execution and we expect the stock to recover, but concede its "noisy" financial presentation is a hurdle to investor engagement in the stock.

ShowHide Related Items >><<
EMR Emerson Electric
$85.43 /

-0.285 (-0.33%)

EMR Emerson Electric
$85.43 /

-0.285 (-0.33%)

02/14/23 Argus
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends
02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
02/09/23 Deutsche Bank
Deutsche Bank keeps Hold on Emerson Electric, lowers price target to $93
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
EMR Emerson Electric
$85.43 /

-0.285 (-0.33%)

EMR Emerson Electric
$85.43 /

-0.285 (-0.33%)

EMR Emerson Electric
$85.43 /

-0.285 (-0.33%)

Downgrade
Argus cuts Emerson Electric to Hold, sees 'problematic' recent trends » 07:35
02/14/23
02/14
07:35
02/14/23
07:35
EMR

Emerson Electric

$86.91 /

+1.065 (+1.24%)

Argus analyst John Eade…

Argus analyst John Eade downgraded Emerson Electric to Hold from Buy. While the company should be able to generate high single-digit earnings growth with 3%-4% revenue growth and margin improvement in the long term, its near-term trends have been "problematic", including a recent Q1 earnings miss due to higher-than-expected stock compensation, the analyst tells investors in a research note. The company is also embarking on a couple of challenging M&A projects, and these could further dilute Emerson management's attention, even though valuations on the stock are "reasonable", the firm adds.

ShowHide Related Items >><<
EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

02/14/23 Argus
Emerson Electric downgraded to Hold from Buy at Argus
02/09/23 Deutsche Bank
Deutsche Bank keeps Hold on Emerson Electric, lowers price target to $93
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
01/17/23 Deutsche Bank
Emerson makes hostile bid for National Instruments, says Deutsche Bank
EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

Downgrade
Emerson Electric downgraded to Hold from Buy at Argus » 07:15
02/14/23
02/14
07:15
02/14/23
07:15
EMR

Emerson Electric

$86.91 /

+1.065 (+1.24%)

Argus analyst John Eade…

Argus analyst John Eade downgraded Emerson Electric to Hold from Buy.

ShowHide Related Items >><<
EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

02/09/23 Deutsche Bank
Deutsche Bank keeps Hold on Emerson Electric, lowers price target to $93
01/18/23 Baird
Aspen Technology price target lowered to $224 from $242 at Baird
01/17/23 Deutsche Bank
Emerson makes hostile bid for National Instruments, says Deutsche Bank
01/09/23 Citi
Citi opens 'positive 90-day catalyst watch' on Rockwell Automation
EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

EMR Emerson Electric
$86.91 /

+1.065 (+1.24%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.